Laobaixing Pharmacy (603883) — Capital Reinvestment Ratio

Latest as of September 2025: 0.09x

Laobaixing Pharmacy (603883) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥538.25 Million) in capital expenditures (CN¥46.44 Million). See Laobaixing Pharmacy free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.09x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥538.25 Million
CNY

Capital Expenditures

CN¥46.44 Million
CNY

Data as of

Sep 2025
Most recent filing

Laobaixing Pharmacy Capital Reinvestment Ratio (2011–2025)

This chart tracks Laobaixing Pharmacy's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Laobaixing Pharmacy (2011–2025)

Year-by-year Capital Reinvestment Ratio for Laobaixing Pharmacy from 2011 to 2025. For live market cap and broader valuation context, see Laobaixing Pharmacy (603883) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.08x CN¥3.14 Billion CN¥253.44 Million ▼ -67.8%
2024 0.25x CN¥2.03 Billion CN¥507.50 Million ▲ +10.1%
2023 0.23x CN¥2.73 Billion CN¥620.87 Million ▲ +70.7%
2022 0.13x CN¥2.31 Billion CN¥308.44 Million ▼ -36.0%
2021 0.21x CN¥2.30 Billion CN¥478.61 Million ▼ -23.5%
2020 0.27x CN¥1.45 Billion CN¥394.27 Million ▼ -34.0%
2019 0.41x CN¥1.03 Billion CN¥426.40 Million ▼ -56.8%
2018 0.96x CN¥913.03 Million CN¥873.41 Million ▲ +54.3%
2017 0.62x CN¥492.13 Million CN¥305.12 Million ▼ -5.6%
2016 0.66x CN¥313.26 Million CN¥205.66 Million ▲ +13.9%
2015 0.58x CN¥257.15 Million CN¥148.17 Million ▲ +21.1%
2014 0.48x CN¥247.14 Million CN¥117.63 Million ▼ -9.8%
2013 0.53x CN¥136.52 Million CN¥72.06 Million ▲ +20.7%
2012 0.44x CN¥148.85 Million CN¥65.10 Million ▲ +64.2%
2011 0.27x CN¥132.62 Million CN¥35.32 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow